Prediction of HER2-positive breast cancer recurrence and metastasis risk from histopathological images and clinical information via multimodal deep learning

[Display omitted] HER2-positive breast cancer is a highly heterogeneous tumor, and about 30% of patients still suffer from recurrence and metastasis after trastuzumab targeted therapy. Predicting individual prognosis is of great significance for the further development of precise therapy. With the c...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Computational and structural biotechnology journal Ročník 20; s. 333 - 342
Hlavní autoři:	Yang, Jialiang, Ju, Jie, Guo, Lei, Ji, Binbin, Shi, Shufang, Yang, Zixuan, Gao, Songlin, Yuan, Xu, Tian, Geng, Liang, Yuebin, Yuan, Peng
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Netherlands Elsevier B.V 01.01.2022 Research Network of Computational and Structural Biotechnology Elsevier
Témata:	biotechnology Breast cancer breast neoplasms cancer recurrence computers Convolutional neural network eosin genome H&E-stained histological images HER2 histopathology hospitals metastasis neural networks patients prediction prognosis Recurrence risk risk assessment surgery Recurrence H&E-stained histological images Breast cancer HER2 Convolutional neural network
ISSN:	2001-0370, 2001-0370
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!